| John Ebisui, DPM | |
|
2227 Olympic Blvd, Walnut Creek, CA 94595-1623 | |
| (925) 634-9704 | |
| Not Available |
| Full Name | John Ebisui |
|---|---|
| Gender | Male |
| Speciality | Podiatrist |
| Location | 2227 Olympic Blvd, Walnut Creek, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093736282 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | E12380 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Ebisui, DPM 350 Peach Tree Ct, A, Brentwood, CA 94513-1625 Ph: () - | John Ebisui, DPM 2227 Olympic Blvd, Walnut Creek, CA 94595-1623 Ph: (925) 634-9704 |
News Archive
Research shows that adolescents who engage in one form of risky behavior, like drug or alcohol use, are likely to engage in other risky behaviors like self-harm, or having unprotected sex, but often times these behaviors are not discussed during a medical or mental health exam.
The proportion of twins born by cesarean delivery in Victoria, Australia increased threefold, from 24% to 71% of all twin births, during 1983–2015, despite high-level evidence that routine cesarean delivery of twins does not benefit mothers or babies, according to the authors of research published online today by the Medical Journal of Australia.
To provide increased value to healthcare facilities, Toshiba America Medical Systems, Inc. expands its Assurance Program to offer reconditioned Toshiba ultrasound systems. Assurance ultrasound products include Aplio XG, Aplio MX, Aplio Artida, Viamo, and Xario XG.
As COVID-19 cases continue to skyrocket across the U.S. and the world, few options are available for treating patients infected with the SARS-CoV-2.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that additional data from a Phase 1 safety and proof-of-concept study evaluating lead candidate, galeterone, in patients with castration-resistant prostate cancer (CRPC) will be highlighted in a poster presentation titled, "Phase I clinical trial of galeterone, a multifunctional anti-androgen and CYP17 inhibitor in castration resistant prostate cancer," abstract number 4665, on Sunday, June 3, 2012, 8:00 a.m. to 12:00 p.m. at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 6 days ago
Dr. Jennifer Kim, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-4000 | |
Cheryl J. Hanson, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-4000 | |
Joseph Raymond Bartis, OPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3300 Tice Creek Dr #8, Walnut Creek, CA 94595 Phone: 925-210-0123 | |
Dr. Ali Khavari, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2637 Shadelands Dr Ste H, Walnut Creek, CA 94598 Phone: 925-464-1982 | |
Eman Elmi, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2637 Shadelands Dr, Walnut Creek, CA 94598 Phone: 925-464-1982 Fax: 925-464-2042 | |
Shayan Essapoor, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2637 Shadelands Dr, Walnut Creek, CA 94598 Phone: 925-464-1982 Fax: 925-464-2042 | |
Cecile Shepard Adobe Foot Clinic Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 106 La Casa Via Ste 270, Walnut Creek, CA 94598 Phone: 925-988-7550 Fax: 925-686-5807 |